(Q42229061)

19 October 2017

title

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection (English)

1 reference

19 October 2017

1

1 reference

19 October 2017

7

Matthew L Albert

1 reference

19 October 2017

3

Armanda Casrouge

1 reference

19 October 2017

Melissa Laird

2

1 reference

19 October 2017

Arvydas Ambrozaitis

4

1 reference

19 October 2017

Roger Williams

5

1 reference

19 October 2017

Nikolai V Naoumov

6

1 reference

19 October 2017

Shilpa Chokshi

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

19 May 2014

1 reference

19 October 2017

1 reference

19 October 2017

volume

60

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

487-496

1 reference

Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions

19 October 2017

cites work

1 reference

Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.

21 January 2018

1 reference

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy

21 January 2018

1 reference

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

21 January 2018

1 reference

CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients

21 January 2018

1 reference

Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection

21 January 2018

1 reference

Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection

21 January 2018

1 reference

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C

21 January 2018

1 reference

Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection

21 January 2018

1 reference

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

21 January 2018

1 reference

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

21 January 2018

1 reference

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

21 January 2018

1 reference

Case definitions for acute hepatitis C virus infection: a systematic review.

21 January 2018

1 reference

NK cells: natural born killers in the conflict between humans and HCV.

21 January 2018

1 reference

Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection

21 January 2018

1 reference

Human natural killer cell development and biology

21 January 2018

1 reference

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

21 January 2018

1 reference

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

21 January 2018

1 reference

Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease

21 January 2018

1 reference

Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.

21 January 2018

1 reference

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection

21 January 2018

1 reference

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

21 January 2018

1 reference

Visualization of the structures of the hepatitis C virus replication complex

21 January 2018

1 reference

Overview of the gliptin class (dipeptidyl peptidase-4 inhibitors) in clinical practice

21 January 2018

1 reference

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

21 January 2018

1 reference

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

21 January 2018

1 reference

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

21 January 2018

1 reference

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

21 January 2018

1 reference

Interleukin-2, interleukin-15, and their roles in human natural killer cells

21 January 2018

1 reference

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

21 January 2018

1 reference

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

21 January 2018

1 reference

Immunological techniques in viral hepatitis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27139

1 reference

19 October 2017

1 reference